The 9th Annual Cancer Genomics Consortium (CGC) meeting was held in Nashville, Tennessee in U.S. in August, 2018. Li Jing, Associate Chief Physician from Hematology Department of the First Affiliated Hospital of Xi’an Jiaotong University, was invited to attend the annual meeting and deliver presentations.
CGC is a non-profit organization by a group of clinical cytogeneticists, molecular geneticists and molecular pathologists, who are committed to development of advanced clinical diagnostic techniques, early application, performance and interpretation of leading edge technologies for cancer and constitutional genomics, and persistent improvement in the analytical methods for experimental data. Hundreds of laboratorians, clinicians and researchers from the U.S. and the globe converged on this annual meeting, which highlighted the major topics of advancing the application of genomic technologies (microarray, next-generation sequencing, massively parallel sequencing,etc.) into the clinical diagnosis of hematologic and solid tumors and developing guidelines and resources for clinical testing.
Under the financial support by Xi’an Jiaotong University and our hospital for attending high-level international conferences, Li Jing, Associate Chief Physician from Hematology Department of our hospital was invited to attend the 9th Annual CGC Meeting and delivered presentations entitled “Application of next-generation sequencing in diagnosis of patients with MDS and AML”. In this paper, she mainly introduced the application of next-generation sequencing technology in the accurate diagnosis, treatment, prognosis stratification and evaluation of clinical efficacy in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), which captivated widespread attention of her peers at home and abroad, showcased the capability and achievements made by Hematology Department in genetic diagnosis and research of hematological malignancies and strengthened the influence of our hospital in the international community of hematology.
